Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -288,585 | -169,451 | -43,832 | N/A |
| Depreciation Amortization | 859 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -4,657 | 16,700 | 1,577 | N/A |
| Other Working Capital | -10,915 | 22,491 | 1,243 | N/A |
| Other Operating Activity | 49,711 | -6,383 | 524 | 0 |
| Operating Cash Flow | $-253,587 | $-136,643 | $-40,488 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,638 | -2,178 | -464 | N/A |
| Purchase Of Investment | -212,899 | N/A | N/A | N/A |
| Other Investing Activity | -1,716 | -18,858 | 0 | 0 |
| Investing Cash Flow | $-217,253 | $-21,036 | $-464 | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | 1,000 | 4,000 | N/A |
| Debt Issued | 36,939 | 56,438 | 132 | N/A |
| Debt Repayment | N/A | -1,097 | N/A | N/A |
| Common Stock Issued | 416,182 | 95,976 | 144 | N/A |
| Dividend Paid | N/A | N/A | -1,151 | N/A |
| Other Financing Activity | -54,329 | 349,231 | 109,858 | 0 |
| Financing Cash Flow | $398,792 | $501,548 | $112,983 | $N/A |
| Beginning Cash Position | 436,245 | 92,376 | 20,345 | N/A |
| End Cash Position | 364,197 | 436,245 | 92,376 | N/A |
| Net Cash Flow | $-72,048 | $343,869 | $72,031 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -253,587 | -136,643 | -40,488 | N/A |
| Capital Expenditure | -2,638 | -2,178 | -464 | N/A |
| Free Cash Flow | -256,225 | -138,821 | -40,952 | 0 |